Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

*Product:*	Clobazam (Max Health)
Active Ingredient:	Clobazam 10mg
Dosage Form:	Tablet
New Zealand Sponsor:	Max Health Limited
Manufacturer:	Micro Labs Limited, Verna, India

*Product:*	Clobazam (Brown & Burk)
Active Ingredient:	Clobazam 10mg
Dosage Form:	Tablet
New Zealand Sponsor:	Max Health Limited
Manufacturer:	Micro Labs Limited, Verna, India

*Product:*	Ferrograd Iron + C
Active Ingredients:	Ferrous sulfate dried 325mg equivalent to elemental iron 105mg Sodium ascorbate 562.4mg equivalent to ascorbic acid 500mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	Neo Pharma Limited
Manufacturer:	Titan Laboratories Pvt Limited, Village Jite, India

*Product:*	Ferrosul Ascocid
Active Ingredients:	Ferrous sulfate dried 325mg equivalent to elemental iron 105mg Sodium ascorbate 562.4mg equivalent to ascorbic acid 500mg
Dosage Form:	Modified release tablet
New Zealand Sponsor:	Neo Pharma Limited
Manufacturer:	Titan Laboratories Pvt Limited, Village Jite, India

*Product:*	Irinotecan
Active Ingredient:	Irinotecan hydrochloride trihydrate 20mg/mL
Dosage Form:	Concentrate for infusion
New Zealand Sponsor:	Alchemy Health Limited
Manufacturer:	Sichuan Huiyu Pharmaceutical Company Limited, Neijiang, China

Dated this 20th day of October 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule